Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
treatment_sodium_bicarbonate [2025/04/13 01:44] – jkohts | treatment_sodium_bicarbonate [2025/04/16 04:26] (current) – [2.2 Salicylate Toxicity] jkohts | ||
---|---|---|---|
Line 2: | Line 2: | ||
===== - Overview ===== | ===== - Overview ===== | ||
+ | Sodium bicarbonate (NaHCO₃) is primarily used in toxicology to treat sodium channel blocker toxicity (e.g. TCA toxicity). | ||
- | + | The patient should then be [[concept_serum_alkalinization|hyperventilated]]. | |
- | Sodium Bicarbonate (NaHCO3) is the primary antidote for [[: | + | |
- | + | ||
- | The patient should then be [[: | + | |
Line 16: | Line 14: | ||
* Also see: Tricyclic antidepressants, | * Also see: Tricyclic antidepressants, | ||
* **Adult:** | * **Adult:** | ||
- | * 💊 **Sodium | + | * 💊 **Sodium |
* **Child:** | * **Child:** | ||
- | * 💊👶 **Sodium | + | * 💊👶 **Sodium |
* Repeat boluses until signs of cardiotoxicity (QRS widening, wide complex dysrhythmias) improve. | * Repeat boluses until signs of cardiotoxicity (QRS widening, wide complex dysrhythmias) improve. | ||
* Do not exceed serum pH 7.55, Na⁺ 155 mmol/L. | * Do not exceed serum pH 7.55, Na⁺ 155 mmol/L. | ||
Line 27: | Line 25: | ||
* Alkalinization therapy in salicylate toxicity works by ↓ CNS redistribution of salicylates (alters drug distribution), | * Alkalinization therapy in salicylate toxicity works by ↓ CNS redistribution of salicylates (alters drug distribution), | ||
* **Adult:** | * **Adult:** | ||
- | * 💊 **Sodium | + | * 💊 **Sodium |
- | * 💊 **Sodium | + | * 💊 **Sodium |
- | * e.g. 150 mmol of Sodium | + | * e.g. 150 mmol of Sodium |
* **Child:** | * **Child:** | ||
- | * 💊👶 **Sodium | + | * 💊👶 **Sodium |
- | * 💊👶 **Sodium | + | * 💊👶 **Sodium |
- | * Maintain normokalemia. | + | |
* Goals: | * Goals: | ||
* Serum pH 7.5-7.55. | * Serum pH 7.5-7.55. | ||
* Urinary pH >7.5. | * Urinary pH >7.5. | ||
* Urine output 2-3 mL/kg/hr. | * Urine output 2-3 mL/kg/hr. | ||
+ | * Maintain normokalemia. | ||
Line 53: | Line 50: | ||
===== - Special Populations ===== | ===== - Special Populations ===== | ||
- | **Renal impairment: | + | **Renal impairment: |
- | + | ||
- | **Hepatic | + | |
Line 68: | Line 63: | ||
==== - Pharmacodynamics ==== | ==== - Pharmacodynamics ==== | ||
- | **Mechanism of action:** Hypertonic | + | **Mechanism of action:** Hypertonic |
Line 90: | Line 85: | ||
==== - Pharmaceutics ==== | ==== - Pharmaceutics ==== | ||
- | **Formulation: | + | **Formulation: |